The present invention relates to invention relates to a sustained release composition of ibuprofen or pharmaceutically acceptable salt thereof, comprising high drug load of active ingredient and its method of preparation. The sustained release pharmaceutical composition comprising ibuprofen or a pharmaceutically acc...

The present invention relates to pharmaceutical compositions of sirolimus or pharmaceutically acceptable salts thereof for oral administration and process of preparation thereof. The pharmaceutical composition of sirolimus comprises an inert core and a drug overcoat, wherein the drug overcoat is devoid of sugar. ...

The present invention relates to slow release pharmaceutical composition comprising cefdinir, a surface-active agent and a rate controlling agent. It also relates to a slow release pharmaceutical composition with a specific dissolution rate by increasing the solubility of cefdinir and simultaneously slows the releas...

The present invention relates to slow release pharmaceutical composition comprising cefdinir, a surface-active agent and a rate controlling agent. It also relates to a slow release pharmaceutical composition with a specific dissolution rate by increasing the solubility of cefdinir and simultaneously slows the rele...

The present invention relates to a stable pharmaceutical composition comprising an active agent containing effective amount of tenofovir disoproxil or a pharmaceutically acceptable salt thereof and an acidic compound and processes for preparing the same. The pharmaceutical composition may optionally contain other an...

Present invention relates to mouth dissolving formulations of apixaban. These Drug delivery systems became sophisticated as pharmaceutical scientists acquire a better understanding of the physicochemical and biochemical parameters pertinent to their performance, Apixaban is an anticoagulant for the treatment of veno...

The present invention relates to a sublingual pharmaceutical composition of teriflunomide used for the treatment of multiple sclerosis. It also relates to processes of preparation of various types of sublingual pharmaceutical composition of teriflunomide and using such compositions.

The present invention provides solid oral pharmaceutical composition of metformin and glimepiride wherein metformin is present as modified release form and glimepiride is present in immediate release form; and metformin in modified release form is presented as core tablet and glimepiride is presented as immediate re...

The present invention relates to nanoparticulate compositions of ivacaftor or a pharmaceutically acceptable salt thereof, and methods of making and using such compositions. The compositions comprise ivacaftor particles having an effective average particle size of less than about 2000 nm. The invention also comprises...

A pharmaceutical aqueous suspension formulation for parenteral administration having substantially stabilized pH comprising a biologically active steroidal compound and excipients, wherein at least one of the excipient used is dried. Preferably, the biologically active compound is a steroidal compound, for instance ...

The present invention relates to a hot melt extruded tenofovir disoproxil or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the same. The invention also relates to the methods of preparation of hot melt extruded tenofovir disoproxil or a pharmaceutically acceptable salt thereo...

The present invention relates to a pharmaceutical composition comprising rivaroxaban or a pharmaceutically acceptable salt thereof, and a surfactant; wherein the rivaroxaban is co-micronized with the surfactant. The rivaroxaban and surfactant is present in a molar ratio from about 0.1:1 to 1:0.1. The co-micronized r...

The present invention relates to a pharmaceutical composition of febuxostat or a pharmaceutically acceptable salt thereof and a method for producing the same. As febuxostat is water insoluble and bioavailability is also low, a pharmaceutical composition of the invention provides both optimum dissolution and absorpti...

The invention relates to a stable tablet composition of fingolimod, a pharmaceutically acceptable salt thereof or a phosphate derivative as an active ingredient and its preparation.

The present invention relates to novel crystalline Form A of Tenofovir disoproxil succinate.. The invention also relates to a pharmaceutical composition comprising an active agent containing effective amount of tenofovir disoproxil succinate crystalline Form A and optionally other anti-HIV drugs. ...

An extended release propafenone mini tablets composition with in vitro release profile similar to that of Rythmol SR capsules without using any release retarding excipient wherein thee concentration of propafenone is less than or equal to 80%w/w.

Abstract The present invention relates to a pharmaceutical composition comprising fingolimod, a pharmaceutically acceptable salt thereof or a phosphate derivative and a zwitterion as a stabilizer. The zwitterion can be present from about 5% to about 95% by weight of the total composition. The invention also relates...

Abstract The present invention relates to a pharmaceutical composition comprising rivaroxaban or a pharmaceutically acceptable salt thereof, wherein the disintegrant is present in an amount of from about 5% to about 90% by weight of the total weight of the composition, preferably from about 10% to about 85% by weig...

Abstract The present invention relates to a pharmaceutical composition comprising an active agent containing effective amount of tenofovir disoproxil oxalate and optionally other anti-HIV drugs. The invention also relates to a pharmaceutical composition comprising an active agent containing effective amount of teno...

A pharmaceutical aqueous suspension formulation for parenteral administration having substantially stabilized pH comprising a biologically active steroidal compound and excipients, wherein at least one of the excipient used is dried. Preferably, the biologically active compound is a steroidal compound, for instance ...

The present invention relates to stable extended release pharmaceutical compositions of Dalfampridine or salts thereof; free of cellulosic diluents. The invention typically relates to processes for the preparation of stable extended release pharmaceutical compositions of Dalfampridine comprising atleast one rate con...

ABSTRACT SOLID DOSAGE FORM OF DASATINIB The present invention relates to delayed release solid dosage forms of dasatinib wherein the delayed release profile is achieved by using hydrophobic or lipophilic material or a suitable polymer in the granulation of the ingredients of composition. The present inventi...

ABSTRACT STABLE SOLID DOSAGE FORM OF SELEXIPAG AND PROCESS FOR PREPARATION THEREOF The present invention relates to stable solid dosage forms of Selexipag and process for preparation of the stable solid dosage for. The present invention also relates to a robust process for preparation of stable solid dosage fo...

SOLID DOSAGE FORMS OF PALBOCICLIB The present invention relates to novel pharmaceutical compositions comprising palbociclib, as the as a pharmaceutically active compound. Specifically, the present invention relates to solid dosage forms of palbociclib comprising at least one compound selected from the group consi...

SUSTAINED RELEASE COMPOSITIONS OF RANOLAZINE The present invention relates to pharmaceutical compositions of Ranolazine or pharmaceutically acceptable salts, polymorphs, solvates, hydrates, enantiomers thereof. In particular the present invention relates to sustained release dosage forms of Ranolazine comprising a ...

ABSTRACT PHARMACEUTICAL COMPOSITIONS OF LICOFELONE The present invention relates to pharmaceutical compositions of Licofelone, or a pharmaceutically acceptable ester, salt or solvate thereof, suitable for oral administration wherein the compositions have good stability also have improved dissolution profile. ...

The present invention relates generally to an intelligent health care management system, and more particularly to a system, method and device for maintaining, updating, and intelligently analyzing patient information to provide diagnostic and therapeutic information.

ABSTRACT: The present invention relates to methods and pharmaceutical compositions for oral administration comprising of Fluvoxamine or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable carrier and process of preparing the same by using wet granulation and direct compression....